http://www.unboundmedicine.com/medline/ebm/research/enoxaparinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19892063/full_citation/Comparison_of_safety_of_subcutaneous_enoxaparin_as_outpatient_anticoagulation_bridging_therapy_in_patients_with_a_mechanical_heart_valve_versus_patients_with_nonvalvular_atrial_fibrillation_Bui HT, Krisnaswami A, Le CU, et al. 
Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation. [Journal Article]
Am J Cardiol 2009 Nov 15; 104(10):1429-33.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19892046/full_citation/Comparison_of_site_reported_and_core_laboratory_reported_creatine_kinase_MB_values_in_non_ST_segment_elevation_acute_coronary_syndrome__from_the_international_trial_SYNERGY__Linefsky JP, Lin M, Pieper KS, et al. 
Comparison of site-reported and core laboratory-reported creatine kinase-MB values in non-ST-segment elevation acute coronary syndrome (from the international trial SYNERGY). [Journal Article, Research Support, Non-U.S. Gov't]
Am J Cardiol 2009 Nov 15; 104(10):1330-5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19890611/full_citation/Extended_prophylaxis_of_venous_thromboembolism_with_fondaparinux_in_patients_undergoing_major_orthopaedic_surgery_in_Italy:_a_cost_effectiveness_analysis_Capri S, Ageno W, Imberti D, et al. 
Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis. [JOURNAL ARTICLE]
Intern Emerg Med 2009 Nov 5.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19888521/full_citation/Structural_features_of_low_molecular_weight_heparins_affecting_their_affinity_to_antithrombin_Bisio A, Vecchietti D, Citterio L, et al. 
Structural features of low-molecular-weight heparins affecting their affinity to antithrombin. [Journal Article]
Thromb Haemost 2009 Nov; 102(5):865-73.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19887383/full_citation/Pharmacokinetics_of_subcutaneous_low_molecular_weight_heparin__enoxaparin__in_dogs_Lunsford KV, Mackin AJ, Langston VC, et al. 
Pharmacokinetics of subcutaneous low molecular weight heparin (enoxaparin) in dogs. [Journal Article]
J Am Anim Hosp Assoc 2009 Nov-Dec; 45(6):261-7.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19877796/full_citation/Cerebral_venous_sinus_thrombosis_associated_with_oral_contraceptives:_the_case_for_neurosurgery_Galarza M, Gazzeri R 
Cerebral venous sinus thrombosis associated with oral contraceptives: the case for neurosurgery. [Journal Article]
Neurosurg Focus 2009 Nov; 27(5):E5.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19865059/full_citation/A_comparison_of_different_treatment_managements_in_patients_with_acute_deep_vein_thrombosis_by_the_effects_on_enhancing_venous_outflow_in_the_lower_limb_Rahman A, Colak MC, Ustunel L, et al. 
A comparison of different treatment managements in patients with acute deep vein thrombosis by the effects on enhancing venous outflow in the lower limb. [Journal Article]
Med Sci Monit 2009 Nov; 15(11):CR588-593.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19860536/full_citation/Safety_evaluation_of_enoxaparin_in_currently_approved_indications_Meneveau N 
Safety evaluation of enoxaparin in currently approved indications. [JOURNAL ARTICLE]
Expert Opin Drug Saf 2009 Oct 27.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19850587/full_citation/FXa_Inhibition_and_Coagulation_Changes_During_DVT_Prophylaxis_by_Enoxaparin_Over_the_Course_of_a_15_Day_Follow_Up_in_Septic_Patients_Zenahlikova Z, Kvasnicka J, Kudrnova Z, et al. 
FXa Inhibition and Coagulation Changes During DVT Prophylaxis by Enoxaparin Over the Course of a 15-Day Follow-Up in Septic Patients. [JOURNAL ARTICLE]
Clin Appl Thromb Hemost 2009 Oct 22.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19847624/full_citation/Hospital_based_costs_associated_with_venous_thromboembolism_prophylaxis_regimens_Merli G, Ferrufino CP, Lin J, et al. 
Hospital-based costs associated with venous thromboembolism prophylaxis regimens. [JOURNAL ARTICLE]
J Thromb Thrombolysis 2009 Jul 15.
Abstract | Full Citation